Atrial fibrillation is a very common sustained arrhythmia, but patients' response to medical and ablation therapy is highly variable. Drs Darbar and Roden expertly review the emerging data on the underlying genetic substrate of this condition, and discuss how understanding the pathological mechanisms might help to tailor antiarrhythmic therapies to individual patients and improve the response to treatment.
- Dawood Darbar
- Dan M. Roden